171
Views
39
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia

, , , , , , , , , , , , , , , , & , MD show all
Pages 1104-1107 | Received 05 Feb 2008, Accepted 21 Mar 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Elham Askari, Sara Rodriguez & Ramon Garcia-Sanz. (2021) Waldenström’s Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy. Journal of Blood Medicine 12, pages 795-807.
Read now
Ilyas Sahin, Houry Leblebjian, Steven P Treon & Irene M Ghobrial. (2014) Waldenström macroglobulinemia: from biology to treatment. Expert Review of Hematology 7:1, pages 157-168.
Read now
Pierre Morel & Giampaolo Merlini. (2012) Risk stratification in Waldenström macroglobulinemia. Expert Review of Hematology 5:2, pages 187-199.
Read now
Guner Hayri Ozsan & Angela Dispenzieri. (2011) Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias. Expert Review of Clinical Immunology 7:1, pages 65-73.
Read now
Meghan Rourke, Kenneth C. Anderson & Irene M. Ghobrial. (2010) Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. Leukemia & Lymphoma 51:10, pages 1779-1792.
Read now

Articles from other publishers (34)

Daniel S Pearson, Dustin S McEvoy, Mandakolathur R Murali & Anand S Dighe. (2023) Use of Clinical Decision Support to Improve the Laboratory Evaluation of Monoclonal Gammopathies. American Journal of Clinical Pathology 159:2, pages 192-204.
Crossref
Morie A. Gertz. (2023) Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. American Journal of Hematology 98:2, pages 348-358.
Crossref
Zdeněk Adam, David Zeman, Luděk Pour, Marta Krejčí, Martin Krejčí, Zdeněk Řehák, Renata Koukalová, Viera Sandecká, Martin Štork, Gabriela Romanová, Zuzana Adamová & Zdeněk Král. (2022) Waldenström´s macroglobulinemia, overview of clinical symptoms, and therapy and our experience with ibrutinib therapy. Onkologie 16:Suppl. B, pages 83-102.
Crossref
Guy Pratt, Dima El‐Sharkawi, Jaimal Kothari, Shirley D’Sa, Rebecca Auer, Helen McCarthy, Rajesh Krishna, Oliver Miles, Charalampia Kyriakou & Roger Owen. (2022) Diagnosis and management of Waldenström macroglobulinaemia—A British Society for Haematology guideline . British Journal of Haematology 197:2, pages 171-187.
Crossref
Jin Seok Kim, Sung-Soo Yoon, Chang-Ki Min, Je-Jung Lee, Dok Hyun Yoon & Kihyun Kim. (2021) Screening Tests for Early Diagnosis of Multiple Myeloma and Related Plasma Cell Disorders. The Korean Journal of Medicine 96:5, pages 371-381.
Crossref
Morie A. Gertz. (2021) Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management. American Journal of Hematology 96:2, pages 258-269.
Crossref
J.-P. Martellosio, X. Leleu, P. Roblot, M. Martin & M. Puyade. (2019) Dosage des chaînes légères libres : indications et méthodes. La Revue de Médecine Interne 40:5, pages 297-305.
Crossref
Morie A. Gertz. (2019) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology 94:2, pages 266-276.
Crossref
Morie A. Gertz. (2017) Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. American Journal of Hematology 92:2, pages 209-217.
Crossref
Marcio Andrade-Campos, Ilda Murillo-Flórez, Ramón García-Sanz & Pilar Giraldo. (2017) Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression. Clinical Chemistry and Laboratory Medicine (CCLM) 55:10.
Crossref
D. Kazmierski, M. L. Palomba & C. Barsigian. (2017) Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia. Case Reports in Hematology 2017, pages 1-4.
Crossref
Eva Kimby, Roger G. Owen & Enrica Morra. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia 265 275 .
Guillemette Fouquet, Stéphanie Poulain, Suzanna Schraen, Efstathios Koulieris, Elisabeth Bertrand, Stéphanie Guidez, Cécile Tomowiak, Marie-Christine Kyrtsonis, Efstathios Kastritis, Irene Ghobrial, Véronique Leblond & Xavier Leleu. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia 239 261 .
Josephine M. Vos, Joshua Gustine, Helmut G. Rennke, Zachary Hunter, Robert J. Manning, Toni E. Dubeau, Kirsten Meid, Monique C. Minnema, Marie-Jose Kersten, Steven P. Treon & Jorge J. Castillo. (2016) Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes. British Journal of Haematology 175:4, pages 623-630.
Crossref
Jorge J. Castillo, M. Lia Palomba, Ranjana Advani & Steven P. Treon. (2016) Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience. Therapeutic Advances in Hematology 7:4, pages 179-186.
Crossref
Kamal Kant Singh Abbi, Margarida Silverman, Umar Farooq, Annick Tricot, Lindsey Dozeman, Kalyan Nadiminti, Matthew D. Krasowski & Guido J. Tricot. (2016) Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma. British Journal of Haematology 174:4, pages 536-540.
Crossref
Morie A. Gertz. (2015) Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management. American Journal of Hematology 90:4, pages 346-354.
Crossref
Thomas E. Witzig, Matthew J. Maurer, Thomas M. Habermann, Brian K. Link, Ivana N.M. Micallef, Grzegorz S. Nowakowski, Stephen M. Ansell, Joseph P. Colgan, David J. Inwards, Luis F. Porrata, Svetomir N. Markovic, Patrick B. Johnston, Yi Lin, Carrie Thompson, Mamta Gupta, Jerry A. Katzmann & James R. Cerhan. (2014) Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma. American Journal of Hematology 89:12, pages 1116-1120.
Crossref
Roger G. Owen, Guy Pratt, Rebecca L. Auer, Rita Flatley, Charalampia Kyriakou, Michael P. Lunn, Francis Matthey, Helen McCarthy, Feargal P. McNicholl, Saad M. Rassam, Simon D. Wagner, Matthew Streetly & Shirley D'Sa. (2014) Guidelines on the diagnosis and management of Waldenström macroglobulinaemia. British Journal of Haematology 165:3, pages 316-333.
Crossref
Morie A. Gertz. (2013) Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management. American Journal of Hematology 88:8, pages 703-711.
Crossref
Roger G. Owen, Robert A. Kyle, Marvin J. Stone, Andy C. Rawstron, Veronique Leblond, Giampaolo Merlini, Ramon Garcia‐Sanz, Enrique M. Ocio, Enrica Morra, Pierre Morel, Kenneth C. Anderson, Christopher J. Patterson, Nikhil C. Munshi, Alessandra Tedeschi, Douglas E. Joshua, Efstathios Kastritis, Evangelos Terpos, Irene M. Ghobrial, Xavier Leleu, Morie A. Gertz, Stephen M. Ansell, William G. Morice, Eva Kimby & Steven P. Treon. (2012) Response assessment in W aldenström macroglobulinaemia: update from the VI th I nternational W orkshop . British Journal of Haematology 160:2, pages 171-176.
Crossref
Irene M. Ghobrial. (2012) Are you sure this is Waldenström macroglobulinemia?. Hematology 2012:1, pages 586-594.
Crossref
Morie A. Gertz. (2012) Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology 87:5, pages 503-510.
Crossref
Karen H. van Hoeven, Rosy E. Joseph, William J. Gaughan, Laura McBride, Elizabeth Bilotti, Ann McNeill, Linda Schmidt, Danielle Schillen & David S. Siegel. (2011) The Anion Gap and Routine Serum Protein Measurements in Monoclonal Gammopathies. Clinical Journal of the American Society of Nephrology 6:12, pages 2814-2821.
Crossref
Morie A. Gertz. (2011) Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management. American Journal of Hematology 86:5, pages 411-416.
Crossref
Xavier Leleu, Efstathios Koulieris, Dimitrios Maltezas, Raphael Itzykson, Wanling Xie, Salomon Manier, Remy Dulery, Eilleen Boyle, Jordan Gauthier, Stéphanie Poulain, Tzenou Tatiana, Panayiotis Panayiotidis, Arthur R. Bradwell, Stephen Harding, Veronique Leblond, Marie-Christine Kyrtsonis & Irene M. Ghobrial. (2011) Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia. Clinical Lymphoma Myeloma and Leukemia 11:1, pages 164-167.
Crossref
David S. Viswanatha, Karen Dyer Montgomery & Kathryn Foucar. 2011. Hematopathology. Hematopathology 221 246 .
Matthew S. Davids, Mandakolathur R. Murali & David J. Kuter. (2010) Serum free light chain analysis. American Journal of Hematology 85:10, pages 787-790.
Crossref
Stephen M. Ansell, Robert A. Kyle, Craig B. Reeder, Rafael Fonseca, Joseph R. Mikhael, William G. Morice, P. Leif Bergsagel, Francis K. Buadi, Joseph P. Colgan, David Dingli, Angela Dispenzieri, Philip R. Greipp, Thomas M. Habermann, Suzanne R. Hayman, David J. Inwards, Patrick B. Johnston, Shaji K. Kumar, Martha Q. Lacy, John A. Lust, Svetomir N. Markovic, Ivana N.M. Micallef, Grzegorz S. Nowakowski, Luis F. Porrata, Vivek Roy, Stephen J. Russell, Kristen E. Detweiler Short, A. Keith Stewart, Carrie A. Thompson, Thomas E. Witzig, Steven R. Zeldenrust, Robert J. Dalton, S. Vincent Rajkumar & Morie A. Gertz. (2010) Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines. Mayo Clinic Proceedings 85:9, pages 824-833.
Crossref
Lucía López-Corral, Ramón García-Sanz & Jesús F. San Miguel. (2010) Aplicaciones del test sérico de cadenas ligeras libres en las gammapatías monoclonales. Medicina Clínica 135:8, pages 368-374.
Crossref
Trista Stankowski‐Drengler, Morie A. Gertz, Jerry A Katzmann, Martha Q. Lacy, Shaji Kumar, Nelson Leung, Suzanne R. Hayman, Francis Buadi, Robert A. Kyle, S. Vincent Rajkumar & Angela Dispenzieri. (2010) Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. American Journal of Hematology 85:6, pages 431-434.
Crossref
Rebecca J Pattenden, Kerri L Davidson & Philip R Wenham. (2009) The value of serum free light chains in a case of Waldenstrom's macroglobulinaemia that produces a type I cryoglobulinaemia. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 46:6, pages 531-532.
Crossref
Abraham M. Varghese, Andy C. Rawstron, A. John Ashcroft, Paul Moreton & Roger G. Owen. (2009) Assessment of Bone Marrow Response in Waldenström's Macroglobulinemia. Clinical Lymphoma and Myeloma 9:1, pages 53-55.
Crossref
Xavier Leleu, Julie Gay, Aldo M. Roccaro, Anne-Sophie Moreau, Stephanie Poulain, Remy Dulery, Berenice Bro Des Champs, Daniela Robu & Irene M. Ghobrial. (2009) Update on therapeutic options in Waldenström macroglobulinemia. European Journal of Haematology 82:1, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.